CX157 Completed Phase 2 Trials for Major depressive disorder, recurrent episode Treatment

Back to CX157
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01246908
Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression